Poinciana Advisors Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Poinciana Advisors Group's LLY Position: Q2 2026 in Review
Poinciana Advisors Group reduced its Eli Lilly (LLY) stake by 18% in Q2 2026, selling an estimated $43.9K and leaving 202 shares worth $242K. The position accounts for 0.18% of the portfolio, ranked #92.
Poinciana Advisors Group first reported a position in LLY in Q1 2025 and has held it in 4 quarters since. The position peaked at $363K in Q1 2025. 3,039 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Poinciana Advisors Group held 202 shares of Eli Lilly worth $242K as of Q2 2026.
- Poinciana Advisors Group sold 43 Eli Lilly shares in Q2 2026, an estimated $43.9K.
- Eli Lilly made up 0.18% of Poinciana Advisors Group's portfolio in Q2 2026, its #92 holding.
- Poinciana Advisors Group first reported a position in Eli Lilly in Q1 2025 and has held it in 4 quarters since.
- Poinciana Advisors Group's Eli Lilly position peaked at $363K in Q1 2025.
- 3,039 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Poinciana Advisors Group's 13F filing for Q2 2026, filed 28 Jul 2026.